ARTICLE | Company News
Taisho and EpiGenesis in asthma deal
February 28, 2001 8:00 AM UTC
EpiGenesis (Cranbury, N.J.) granted Taisho (Tokyo, Japan) exclusive rights in Asia to its EPI-2010 antisense oligonucleotide against the adenosine A1 receptor to treat asthma. Taisho also received a c...